232 related articles for article (PubMed ID: 25776942)
1. Dietary management of labrador retrievers with subclinical hepatic copper accumulation.
Fieten H; Biourge VC; Watson AL; Leegwater PA; van den Ingh TS; Rothuizen J
J Vet Intern Med; 2015; 29(3):822-7. PubMed ID: 25776942
[TBL] [Abstract][Full Text] [Related]
2. Dietary management of hepatic copper accumulation in Labrador Retrievers.
Hoffmann G; Jones PG; Biourge V; van den Ingh TS; Mesu SJ; Bode P; Rothuizen J
J Vet Intern Med; 2009; 23(5):957-63. PubMed ID: 19627473
[TBL] [Abstract][Full Text] [Related]
3. Association of dietary copper and zinc levels with hepatic copper and zinc concentration in Labrador Retrievers.
Fieten H; Hooijer-Nouwens BD; Biourge VC; Leegwater PA; Watson AL; van den Ingh TS; Rothuizen J
J Vet Intern Med; 2012; 26(6):1274-80. PubMed ID: 22998127
[TBL] [Abstract][Full Text] [Related]
4. Nutritional management of inherited copper-associated hepatitis in the Labrador retriever.
Fieten H; Biourge VC; Watson AL; Leegwater PA; van den Ingh TS; Rothuizen J
Vet J; 2014 Mar; 199(3):429-33. PubMed ID: 24439471
[TBL] [Abstract][Full Text] [Related]
5. Hepatic copper concentrations in Labrador Retrievers with and without chronic hepatitis: 72 cases (1980-2010).
Johnston AN; Center SA; McDonough SP; Wakshlag JJ; Warner KL
J Am Vet Med Assoc; 2013 Feb; 242(3):372-80. PubMed ID: 23327181
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity and Specificity of Plasma ALT, ALP, and Bile Acids for Hepatitis in Labrador Retrievers.
Dirksen K; Burgener IA; Rothuizen J; van den Ingh TSGAM; Penning LC; Spee B; Fieten H
J Vet Intern Med; 2017 Jul; 31(4):1017-1027. PubMed ID: 28543991
[TBL] [Abstract][Full Text] [Related]
7. Copper-associated chronic hepatitis in Labrador Retrievers.
Hoffmann G; van den Ingh TS; Bode P; Rothuizen J
J Vet Intern Med; 2006; 20(4):856-61. PubMed ID: 16955809
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte-derived microRNAs as sensitive serum biomarkers of hepatocellular injury in Labrador retrievers.
Dirksen K; Verzijl T; van den Ingh TS; Vernooij JC; van der Laan LJ; Burgener IA; Spee B; Fieten H
Vet J; 2016 May; 211():75-81. PubMed ID: 27021912
[TBL] [Abstract][Full Text] [Related]
9. D-penicillamine treatment of copper-associated hepatitis in Labrador retrievers.
Fieten H; Dirksen K; van den Ingh TS; Winter EA; Watson AL; Leegwater PA; Rothuizen J
Vet J; 2013 Jun; 196(3):522-7. PubMed ID: 23375251
[TBL] [Abstract][Full Text] [Related]
10. Acquired proximal renal tubular dysfunction in 9 Labrador Retrievers with copper-associated hepatitis (2006-2012).
Langlois DK; Smedley RC; Schall WD; Kruger JM
J Vet Intern Med; 2013; 27(3):491-9. PubMed ID: 23527903
[TBL] [Abstract][Full Text] [Related]
11. Canine Copper-Associated Hepatitis.
Dirksen K; Fieten H
Vet Clin North Am Small Anim Pract; 2017 May; 47(3):631-644. PubMed ID: 28063745
[TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of copper, zinc and iron with and without D-penicillamine administration in relation to hepatic copper concentration in dogs.
Fieten H; Hugen S; van den Ingh TS; Hendriks WH; Vernooij JC; Bode P; Watson AL; Leegwater PA; Rothuizen J
Vet J; 2013 Aug; 197(2):468-73. PubMed ID: 23583003
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of COMMD1 in copper toxicosis in Labrador retrievers and Dobermans.
Wu X; Mandigers PJJ; Fieten H; Leegwater PA
Vet J; 2020 Nov; 265():105561. PubMed ID: 33129558
[TBL] [Abstract][Full Text] [Related]
14. Chronic hepatitis in Labrador Retrievers: clinical presentation and prognostic factors.
Shih JL; Keating JH; Freeman LM; Webster CR
J Vet Intern Med; 2007; 21(1):33-9. PubMed ID: 17338147
[TBL] [Abstract][Full Text] [Related]
15. Copper-associated hepatitis in Labrador Retrievers.
Smedley R; Mullaney T; Rumbeiha W
Vet Pathol; 2009 May; 46(3):484-90. PubMed ID: 19176511
[TBL] [Abstract][Full Text] [Related]
16. Association of the canine ATP7A and ATP7B with hepatic copper accumulation in Dobermann dogs.
Wu X; Mandigers PJJ; Watson AL; van den Ingh TSGAM; Leegwater PAJ; Fieten H
J Vet Intern Med; 2019 Jul; 33(4):1646-1652. PubMed ID: 31254371
[TBL] [Abstract][Full Text] [Related]
17. ATP7A, ATP7B, and RETN genotypes in Labrador Retrievers with and without copper-associated hepatopathy.
Langlois DK; Nagler BSM; Smedley RC; Yang YT; Yuzbasiyan-Gurkan V
J Am Vet Med Assoc; 2022 Apr; 260(14):1-8. PubMed ID: 35482566
[TBL] [Abstract][Full Text] [Related]
18. Predicting copper toxicosis: relationship between the ATP7A and ATP7B gene mutations and hepatic copper quantification in dogs.
Pindar S; Ramirez C
Hum Genet; 2019 May; 138(5):541-546. PubMed ID: 31062085
[TBL] [Abstract][Full Text] [Related]
19. Erythrocyte copper chaperone for superoxide dismutase and superoxide dismutase as biomarkers for hepatic copper concentrations in Labrador retrievers.
Dirksen K; Roelen YS; van Wolferen ME; Kruitwagen HS; Penning LC; Burgener IA; Spee B; Fieten H
Vet J; 2016 Dec; 218():1-6. PubMed ID: 27938702
[TBL] [Abstract][Full Text] [Related]
20. Use of 2,3,2-tetramine as a hepatic copper chelating agent for treatment of copper hepatotoxicosis in Bedlington terriers.
Twedt DC; Hunsaker HA; Allen KG
J Am Vet Med Assoc; 1988 Jan; 192(1):52-6. PubMed ID: 3343179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
